PolyPid (PYPD) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $4.22
• Market Cap: $78.09M
• EPS: $-2.09
• 52-Week High: $5.12
• 52-Week Low: $2.30

Market Sentiment

PolyPid currently has a Bullish sentiment score of 0.24.

About PolyPid

PolyPid Ltd. is a pioneering biopharmaceutical company based in Petah Tikva, Israel, dedicated to the development of innovative therapies through its proprietary Polymer Lipid Encapsulation Matrix (PLEX) technology. With a robust pipeline targeting local infections and enhancing surgical outcomes, PolyPid addresses significant unmet medical needs in the healthcare sector. Positioned within a dynamic biotech ecosystem, the company is well-placed to pursue strategic collaborations and drive adv...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for PolyPid and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does PYPD pay dividends?

PolyPid (PYPD) does not currently pay a regular dividend.

What is PYPD's market cap?

PolyPid (PYPD) has a market capitalization of $78.09M with a current stock price of $4.22.